A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2001
11/29/2001	CA2410293A1 Three-layer parenteral preparations
11/29/2001	CA2410219A1 Prolonged release microspheres for injection delivery and preparation method
11/29/2001	CA2410101A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/29/2001	CA2410096A1 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	CA2410094A1 Compositions and methods for modulating tumor specific expression
11/29/2001	CA2410083A1 Mammalian receptor proteins; related reagents and methods
11/29/2001	CA2410082A1 Dnax toll-like receptor 7 (dtlr7) protein, related reagents and methods
11/29/2001	CA2410081A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/29/2001	CA2409991A1 Bispecific immunoglobulin-like antigen binding proteins and method of production
11/29/2001	CA2409956A1 Use of ciliary neurotrophic factor
11/29/2001	CA2409868A1 Modulaton of alpha-6 integrin-mediated responses
11/29/2001	CA2409592A1 Pharmceutical compositions comprising vip-related peptides for the treatment of sexual disorders
11/29/2001	CA2409299A1 Compositions and methods for the therapy and diagnosis of breast cancer
11/29/2001	CA2408883A1 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
11/29/2001	CA2408743A1 Method of detecting inflammatory lung disorders
11/29/2001	CA2408739A1 Novel proteins and nucleic acids encoding same, diagnostic and therapeutic uses
11/29/2001	CA2408566A1 Role of ldl receptor protein-1 (lrp-1) in alzheimer's disease
11/29/2001	CA2408387A1 A ligand for enhancing oral and cns delivery of biological agents
11/29/2001	CA2408315A1 Aminoacyl trna synthetases
11/29/2001	CA2408141A1 Neurotransmitter transporters
11/29/2001	CA2408140A1 G-protein coupled receptors
11/29/2001	CA2408125A1 Synthetic peptides and uses therefore
11/29/2001	CA2408036A1 Combination of growth hormone secretagogues and antidepressants
11/29/2001	CA2408022A1 Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof
11/29/2001	CA2407784A1 Treatment of acute coronary syndrome with glp-1
11/29/2001	CA2407570A1 Compositions and methods for delivery of a molecule into a cell
11/29/2001	CA2407545A1 Crystal structures of p-selectin, p- and e-selectin complexes, and uses thereof
11/29/2001	CA2405871A1 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
11/28/2001	EP1158049A1 Myosin-like gene expressed in human heart and muscle
11/28/2001	EP1158046A1 Superoxide Dismutase-4
11/28/2001	EP1158004A2 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
11/28/2001	EP1158002A1 Human G-protein coupled receptor
11/28/2001	EP1157998A1 Heterocyclic compounds, intermediates thereof and elastase inhibitors
11/28/2001	EP1157987A1 S-nitrosothiols as agents for the treatment of circulatory dysfunctions
11/28/2001	EP1157703A2 Sustained release of peptides from pharmaceutical compositions
11/28/2001	EP1157702A1 Compositions comprising DNA Damaging Agents and p53
11/28/2001	EP1157695A1 Method of treating obesity using a neurotensin receptor ligand
11/28/2001	EP1157684A2 Oxidising composition and uses for dyeing, permanently setting or bleaching keratin fibers
11/28/2001	EP1157275A1 Novel transduction molecules and methods for using same
11/28/2001	EP1157274A1 Methods of determining altered ndpk functions
11/28/2001	EP1157126A1 Method for cloning signal transduction intermediates
11/28/2001	EP1157122A1 Anti-neoplastic compositions and uses thereof
11/28/2001	EP1157118A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
11/28/2001	EP1157111A1 Angiopoietin-related protein and nucleic acids
11/28/2001	EP1157108A1 Methods and reagents for inhibiting proliferation of smooth muscle cells
11/28/2001	EP1157102A1 Inhibition of the mhc class ii antigen presentation pathway and presentation to cd4+ cells
11/28/2001	EP1157101A1 Drug design based on the structure of lta 4? hydrolase
11/28/2001	EP1157099A2 Substances for controlling fertility
11/28/2001	EP1157041A2 Antibodies for cancer therapy and diagnosis
11/28/2001	EP1157040A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
11/28/2001	EP1157037A1 Gcsf conjugates
11/28/2001	EP1157036A1 Immunomodulating glycopeptide
11/28/2001	EP1157035A1 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
11/28/2001	EP1157034A1 Process for production of diphtheria toxin
11/28/2001	EP1157033A1 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
11/28/2001	EP1157032A2 Lectomedin materials and methods
11/28/2001	EP1157030A1 Echinocandin/carbohydrate complexes
11/28/2001	EP1156852A2 Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or h 2? receptor antagonists
11/28/2001	EP1156824A2 Compositions and methods for treating cancer and hyperproliferative disorders
11/28/2001	EP1156823A1 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
11/28/2001	EP1156822A1 Treatment of infertility
11/28/2001	EP1156821A1 Treatment of infertility
11/28/2001	EP1156820A1 Vascular endothelial growth factor-2
11/28/2001	EP1156819A1 Methods and compositions for modulating fertility
11/28/2001	EP1156818A2 Methods and compositions for regulating protein-protein interactions
11/28/2001	EP1156817A1 Controlling protein levels in eucaryotic organisms
11/28/2001	EP1156816A1 Peptides modulating activities of heparin, other glycosaminoglycans or proteoglycans
11/28/2001	EP1156811A2 Copper agonist that binds on the copper binding site of app and/or exerts an inhibiting effect on the release of amyloid a beta peptide
11/28/2001	EP1156809A1 Mucin containing ophthalmic preparations
11/28/2001	EP1156808A2 Enhancement of return to independent living status with a growth hormone secretagogue
11/28/2001	EP1156797A2 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
11/28/2001	EP1156787A1 Oxadiazole compounds and compositions for delivering active agents
11/28/2001	EP1156784A1 Processes for making pharmaceutical oral ecb formulations and compositions
11/28/2001	EP1156782A1 Echinocandin pharmaceutical formulations containing micelle-forming surfactants
11/28/2001	EP1156771A2 Interferon tau mutants and methods for making them
11/28/2001	EP1156770A1 Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
11/28/2001	EP1156759A1 Biodegradable polymeriprotein based coils for intralumenal implants
11/28/2001	EP1054685B1 Liquid crystal forms of cyclosporin
11/28/2001	EP1032588A4 Interaction of alpha-conotoxin peptides with neuronal nicotinic acetylcholine receptors
11/28/2001	EP0853483A4 Novel peptides
11/28/2001	EP0845993B1 Use of plasminogene activators to stimulate local bone growth
11/28/2001	EP0845032B1 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
11/28/2001	EP0837845B1 Herpes ribonucleotide reductase inhibitors
11/28/2001	EP0835326A4 Nucleic acid encoding a signal mediator protein that induces cellular morphological alterations
11/28/2001	EP0817622B1 Medicament with angiotensin converting enzyme (ace) inhibitors suitable for transdermal application
11/28/2001	EP0804469B1 T-cell affecting peptides
11/28/2001	EP0804225B1 Pharmaceutical compositions comprising a superoxide dismutase
11/28/2001	EP0789588A4 Method for making a medicament for treating secondary immunodeficiency
11/28/2001	EP0750672B1 Dna sequences for matrix metalloproteases, their production and use
11/28/2001	EP0708671B1 Drug delivery
11/28/2001	EP0698108B1 Adenoviral vectors of animal origin and use thereof in gene therapy
11/28/2001	EP0692966B1 A process for separation of components from red blood cells
11/28/2001	EP0512076B1 Method of treating cancer using structured lipids
11/28/2001	CN1324406A DNA molecules encoding MUC-1 and use thereof in tumor vaccination
11/28/2001	CN1324405A Novel G protein-coupled receptor proteins, DNAS thereof and ligands to the same
11/28/2001	CN1324404A Novel tumor antigen protein SART-3 and tumor antigen peptide thereof
11/28/2001	CN1324403A PRV-1 gene and the use thereof
11/28/2001	CN1324374A Biodegradable low molecular weight triblock polyester polyethylene glocol copolymers having reverse thermal gelation properties
11/28/2001	CN1324367A Cyclic prosaposin-derived peptides and uses thereof
11/28/2001	CN1324363A Calcium (3S) tetrahydro-3-furanyl (1S, 2R)-3-[[(4-aminophenyl)sulfonyl] (isobutyl) amino]-1-benzyl-2-(phosphonooxy) propylcarbamate

1 ... 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 ... 3163